Liu, Xian
Amgen (United States)
2 papers on CoChatORCID 0000-0001-6546-3725
Most cited papers
- Verified
The effect of BIM deletion polymorphism on intrinsic resistance and clinical outcome of cancer patient with kinase inhibitor therapy
Ying, H.-Q., Chen, J., He, B.-S., Pan, Y.-Q., Wang, F., Deng, Q.-W., Sun, H.-L., Liu, X., & Wang, S.-K. (2015) · Scientific Reports
Lung Cancer Treatments and MutationsPharmacogenetics and Drug Metabolism
Cited by 29
- Verified
Brief report: STING expressed in tumor and non-tumor compartments has distinct roles in regulating anti-tumor immunity
Kim, J. C., Liu, X., Fitzgerald, K., Eng, J. S., Orf, J., O’Brien, S. A., Belmontes, B., Casbon, A.-J., Novitskiy, S. V., Tarbell, K. V., et al. (2023) · Cancer Immunology, Immunotherapy
interferon and immune responsesCancer Immunotherapy and Biomarkers
Cited by 22
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free